TPIDB > Principal Investigator
Principal Investigator
更新時間：2025-11-04
吳丁樹Wu, Ting-Shu
- Principal Investigator
- Clinical Trial Experience (year)
-
2626@cgmh.org.tw
Publication
18Publications
1
Lin YC, Lee HH, Lao CK, Yang JH, Chen NY, Yeh CF, Huang PY, Shie SS, Huang WC, Lin CW, Li SH, Wang CL, Lin SW, Huang CC, Lu JJ, Chiu CH, Lai HC, Wu TS*. A retrospective cohort study of Mycobacterium kansasii complex pulmonary infections at a tertiary teaching hospital. J Microbiol Immunol Infect. 2025 Aug 12:S1684-1182(25)00154-9.
2
Lin H-M, Shu C-C, Chen C-H, Chen N-Y, Yang J-H, Chen C-H, Li S-H, Wang C-L, Yu C-T, Lin S-M, Kao K-C, Huang C-C, Yang C-T, Lu J-J, Chiu C-H, Lai H-C, Wu T-S*. Heterogeneity among Mycobacterium avium complex species isolated from pulmonary infection in Taiwan. Microbiol Spectr. 2025 Aug 5;13(8):e0030925. Epub 2025 Jul 7.
3
Peng JJ, Ding JY, Xu Y, Shih HP, Lin YN, Wu TY, Lo YF, Lo CC, Yeh CF, Kuo CY, Tu KH, Wang SY, Lei WT, Wu TS, Lin HS, Lee CH, Huang WC, Chen YC, Liu YM, Shi ZY, Chang YT, Syue LS, Chen PL, Teh SH, Chou CH, Ho MW, Chi CY, Ho PC, Ku CL*. Chimeric autoantibody receptor T cells clonally eliminate B cells producing autoantibodies against IFN-γ. Sci Immunol. 2025 May 9;10(107):eadm8186. Epub 2025 May 9.
4
Chen NY, Cheng CY, Lo SH, Lu PL, Yang CJ, Tseng CY, Tsai HC, Wu TS, Hsiao YH, Liu ZH, Ku SW. Prevalence of Naturally Occurring HIV-1 Capsid Inhibitor Resistance-Related Mutations in Antiretroviral Therapy-Naïve and -Experienced Individuals in Taiwan. Open Forum Infect Dis. 2025 Jan 17;12(2):ofaf028. eCollection 2025 Feb.
5
Chiang TT, Chiang MH, Tang HJ, Shi ZY, Ho MW, Chou CH, Lin SY, Lu PL, Wu TS, Shie SS, Liu JW, Chang FY, Chuang YC, Wang FD*, Yang YS**. Multicenter study on clinical outcomes and poor prognostic factors in patients with Klebsiella pneumoniae bacteremia receiving cefoperazone/sulbactam treatment. Eur J Clin Microbiol Infect Dis. 2024 Sep;43(9):1777-1785.
6
Chao AS*, Lin CY, Chiang MH, Lu KY, Tsai CK, Chen KJ, Chien CW, Wu TS, Chang YL, Chao A, Lin G, Chiu CY**. Metabolomic profiling of maternal plasma identifies inverse associations of acetate and urea with anti-SARS-CoV-2 antibody titers following COVID-19 vaccination during pregnancy. J Mol Med (Berl). 2024 Jun;102(6):819-830.
7
Chen RZ, Lu PL, Yang TY, Lin SY, Tang HJ, Chang FY, Yang YS, Chiang TT, Wang FD, Wu TS, Shie SS, Ho MW, Liu JW, Shi ZY, Chou CH*, Chuang YC. Efficacy of cefoperazone/sulbactam for ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and the factors associated with poor outcomes. J Antimicrob Chemother. 2024 Mar 1;79(3):648-655.
8
Pang AH, Lin SW, Yang JH, Wang PH, Pan SW, Wei YF, Chen CY, Lee HS, Wu TS, Chang CH, Shu CC*. (Observational Study) The timing of intravenous antibiotics and clinical outcomes of Mycobacterium abscessus complex lung diseases. Int J Tuberc Lung Dis. 2024 Feb 1;28(2):73-80.
9
Lin TL, Kuo YL, Lai JH, Lu CC, Yuan CT, Hsu CY, Yan BS, Wu LS, Wu TS, Wang JY, Yu CJ, Lai HC, Shu JC, Shu CC*. Gut microbiota dysbiosis-related susceptibility to nontuberculous mycobacterial lung disease. Gut Microbes. 2024 Jan-Dec;16(1):2361490.
10
Lao CK, Ou JH, Fan YC, Wu TS*, Sun PL**. Clinical manifestations and susceptibility of Scedosporium/Lomentospora infections at a tertiary medical centre in Taiwan from 2014 to 2021: A retrospective cohort study. Mycoses. 2023 Oct;66(10):923-935.
1
2
